Verastem reported $172.5M in Market Capitalization this August of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 435.86B 8.73B Aug/2026
Alaunos Therapeutics USD 7M 2M Mar/2026
AstraZeneca USD 178.16B 111.83B Aug/2026
Curis USD 10M 2M Aug/2026
Cytokinetics USD 9.6B 1.95B Aug/2026
Gilead Sciences USD 168.68B 11.82B Aug/2026
Incyte USD 26.84B 4.19B Aug/2026
Laboratory Of America USD 22.96B 1.03B Jun/2026
Novartis USD 240.59B 67.17B Jun/2026
Pfizer USD 153.17B 14.73B Aug/2026
Roche Holding CHF 270B 3.66B Jun/2026
TG Therapeutics USD 7.63B 778M Aug/2026
Verastem USD 147M 319M Aug/2026